CLN Stat
PermalinkRecommendFacebookEmailComments
An upcoming webinar will explore what laboratorians need to know about new risk assessment guidelines for cholesterol management and cardiovascular disease (CVD), which are expected to heavily impact how doctors treat CVD and manage those taking cholesterol-lowering statin medications. Cardiovascu...(Read More)
PermalinkRecommendFacebookEmailComments
The Food and Drug Administration (FDA) on July 31 notified Congress of its intent to issue draft guidance for regulatory oversight of lab-developed tests​ (LDTs), with draft guidance documents to be released no sooner than 60 days afterward. In light of this major regulatory change, AACC is sponso...(Read More)
PermalinkRecommendFacebookEmailComments
New research, published in Clinical Chemistry, may lead laboratorians to take a close look at their quality control efforts for HbA1c test results. As the study notes, “considerable differences in the probability of reporting unreliable HbA1c results between different NGSP (formerly the National Gl...(Read More)
PermalinkRecommendFacebookEmailComments
AACC this fall will offer a first-of-its-kind virtual meeting—which will happen entirely online—focusing on personalized diagnostics, or laboratory analyses that inform the practice of personalized medicine. “Personalized Diagnostics Today: Where the Omics Community Collaborates,” will feature Eric...(Read More)
1 - 4 Next